|
|
Article: Juvaris BioTherapeutics Announces Progress in Alliance with Bayer Animal Health.
- Article from:
- Business Wire
- Article date:
- January 9, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Milestone in evaluation of products for animal health market
BURLINGAME, Calif. -- Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines and immunotherapeutics for infectious diseases and cancer, today announced the achievement of a milestone event in its licensing agreement with Bayer HealthCare's Animal Health Division for the evaluation of Juvaris' technology for applications in animal health markets.
Bayer Animal Health has completed the first evaluation period examining the Juvaris cationic lipid-DNA technology in multiple disease settings in animal health including proof of concept in important food producing animal ...